Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Treasury Shares (2020 - 2023)

Historic Treasury Shares for Cullinan Therapeutics (CGEM) over the last 4 years, with Q3 2023 value amounting to $85.6 million.

  • Cullinan Therapeutics' Treasury Shares changed N/A to $85.6 million in Q3 2023 from the same period last year, while for Sep 2023 it was $85.6 million, marking a year-over-year change of. This contributed to the annual value of $369000.0 for FY2022, which is 41450674.16% up from last year.
  • Latest data reveals that Cullinan Therapeutics reported Treasury Shares of $85.6 million as of Q3 2023.
  • Cullinan Therapeutics' 5-year Treasury Shares high stood at $85.6 million for Q2 2023, and its period low was $89.0 during Q4 2021.
  • For the 4-year period, Cullinan Therapeutics' Treasury Shares averaged around $34.4 million, with its median value being $369000.0 (2022).
  • As far as peak fluctuations go, Cullinan Therapeutics' Treasury Shares crashed by 9997.55% in 2021, and later surged by 41450674.16% in 2022.
  • Cullinan Therapeutics' Treasury Shares (Quarter) stood at $364000.0 in 2020, then tumbled by 99.98% to $89.0 in 2021, then skyrocketed by 414506.74% to $369000.0 in 2022, then soared by 23097.83% to $85.6 million in 2023.
  • Its last three reported values are $85.6 million in Q3 2023, $85.6 million for Q2 2023, and $369000.0 during Q4 2022.